193 related articles for article (PubMed ID: 20093514)
1. Noninvasive contrast-enhanced US quantitative assessment of tumor microcirculation in a murine model: effect of discontinuing anti-VEGF therapy.
Guibal A; Taillade L; Mulé S; Comperat E; Badachi Y; Golmard JL; Le Guillou-Buffello D; Rixe O; Bridal SL; Lucidarme O
Radiology; 2010 Feb; 254(2):420-9. PubMed ID: 20093514
[TBL] [Abstract][Full Text] [Related]
2. Can the effect of antiangiogenic treatments be monitored and quantified noninvasively by using contrast-enhanced US?
Forsberg F
Radiology; 2010 Feb; 254(2):317-8. PubMed ID: 20093504
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of tumor blood flow in mice after treatment with different doses of an antiangiogenic agent with contrast-enhanced destruction-replenishment US.
Zhou JH; Cao LH; Liu JB; Zheng W; Liu M; Luo RZ; Han F; Li AH
Radiology; 2011 May; 259(2):406-13. PubMed ID: 21292869
[TBL] [Abstract][Full Text] [Related]
4. Bevacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy.
Dickson PV; Hamner JB; Sims TL; Fraga CH; Ng CY; Rajasekeran S; Hagedorn NL; McCarville MB; Stewart CF; Davidoff AM
Clin Cancer Res; 2007 Jul; 13(13):3942-50. PubMed ID: 17606728
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced ultrasound with perflubutane in the assessment of anti-angiogenic effects: early prediction of the anticancer activity of bevacizumab in a mouse xenografted model.
Watanabe R; Munemasa T; Matsumura M
Ultrasound Med Biol; 2015 Sep; 41(9):2497-505. PubMed ID: 26022792
[TBL] [Abstract][Full Text] [Related]
6. Molecular ultrasound imaging using a targeted contrast agent for assessing early tumor response to antiangiogenic therapy.
Sorace AG; Saini R; Mahoney M; Hoyt K
J Ultrasound Med; 2012 Oct; 31(10):1543-50. PubMed ID: 23011617
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced Ultrasound Imaging of Antiangiogenic Tumor Therapy.
Klotz LV; Clevert DA; Scheckinger S; Strieth S; Eichhorn ME
Anticancer Res; 2015 May; 35(5):2571-6. PubMed ID: 25964532
[TBL] [Abstract][Full Text] [Related]
8. Contrast ultrasound imaging for identification of early responder tumor models to anti-angiogenic therapy.
Sirsi SR; Flexman ML; Vlachos F; Huang J; Hernandez SL; Kim HK; Johung TB; Gander JW; Reichstein AR; Lampl BS; Wang A; Hielscher AH; Kandel JJ; Yamashiro DJ; Borden MA
Ultrasound Med Biol; 2012 Jun; 38(6):1019-29. PubMed ID: 22425376
[TBL] [Abstract][Full Text] [Related]
9. Regions of interest and parameters for the quantitative analysis of contrast-enhanced ultrasound to evaluate the anti-angiogenic effects of bevacizumab.
Zhang HP; Shi QS; Li F; Liu L; Bai M; Gu JY; Wu Y; Du LF
Mol Med Rep; 2013 Jul; 8(1):154-60. PubMed ID: 23722237
[TBL] [Abstract][Full Text] [Related]
10. Advanced hepatocellular carcinoma: early evaluation of response to bevacizumab therapy at dynamic contrast-enhanced US with quantification--preliminary results.
Lassau N; Koscielny S; Chami L; Chebil M; Benatsou B; Roche A; Ducreux M; Malka D; Boige V
Radiology; 2011 Jan; 258(1):291-300. PubMed ID: 20980447
[TBL] [Abstract][Full Text] [Related]
11. Effect of bevacizumab, a humanized monoclonal antibody to vascular endothelial growth factor, on peritoneal metastasis of MNK-45P human gastric cancer in mice.
Ninomiya S; Inomata M; Tajima M; Ali AT; Ueda Y; Shiraishi N; Kitano S
J Surg Res; 2009 Jun; 154(2):196-202. PubMed ID: 19329124
[TBL] [Abstract][Full Text] [Related]
12. Intra-Animal Comparison between Three-dimensional Molecularly Targeted US and Three-dimensional Dynamic Contrast-enhanced US for Early Antiangiogenic Treatment Assessment in Colon Cancer.
Wang H; Lutz AM; Hristov D; Tian L; Willmann JK
Radiology; 2017 Feb; 282(2):443-452. PubMed ID: 27490690
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis inhibitors in a murine neuroblastoma model: quantitative assessment of intratumoral blood flow with contrast-enhanced gray-scale US.
McCarville MB; Streck CJ; Dickson PV; Li CS; Nathwani AC; Davidoff AM
Radiology; 2006 Jul; 240(1):73-81. PubMed ID: 16793972
[TBL] [Abstract][Full Text] [Related]
14. Anti-VEGF antibody therapy induces tumor hypoxia and stanniocalcin 2 expression and potentiates growth of human colon cancer xenografts.
Miyazaki S; Kikuchi H; Iino I; Uehara T; Setoguchi T; Fujita T; Hiramatsu Y; Ohta M; Kamiya K; Kitagawa K; Kitagawa M; Baba S; Konno H
Int J Cancer; 2014 Jul; 135(2):295-307. PubMed ID: 24375080
[TBL] [Abstract][Full Text] [Related]
15. Genetic delivery of the murine equivalent of bevacizumab (avastin), an anti-vascular endothelial growth factor monoclonal antibody, to suppress growth of human tumors in immunodeficient mice.
Watanabe M; Boyer JL; Hackett NR; Qiu J; Crystal RG
Hum Gene Ther; 2008 Mar; 19(3):300-10. PubMed ID: 18324912
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of bevacizumab on the angiogenesis and growth of retinoblastoma.
Lee SY; Kim DK; Cho JH; Koh JY; Yoon YH
Arch Ophthalmol; 2008 Jul; 126(7):953-8. PubMed ID: 18625942
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric monitoring of early response to antiangiogenic therapy: a sequential perfusion CT and PET/CT study in a rabbit VX2 tumor model.
Kim JI; Lee HJ; Kim YJ; Kim KG; Lee KW; Lee JH; Lee HJ; Lee WW
ScientificWorldJournal; 2014; 2014():701954. PubMed ID: 25383376
[TBL] [Abstract][Full Text] [Related]
18. Contrast ultrasonography: necessity of linear data processing for the quantification of tumor vascularization.
Peronneau P; Lassau N; Leguerney I; Roche A; Cosgrove D
Ultraschall Med; 2010 Aug; 31(4):370-8. PubMed ID: 20577941
[TBL] [Abstract][Full Text] [Related]
19. Monitoring Dual VEGF Inhibition in Human Pancreatic Tumor Xenografts With Dynamic Contrast-Enhanced Ultrasound.
Lamuraglia M; Barrois G; Le Guillou-Buffello D; Santin M; Kerbol A; Comperat E; Coron A; Lucidarme O; Bridal SL
Technol Cancer Res Treat; 2020; 19():1533033819886896. PubMed ID: 32065066
[TBL] [Abstract][Full Text] [Related]
20. VEGFR2-Targeted Contrast-Enhanced Ultrasound to Distinguish between Two Anti-Angiogenic Treatments.
Payen T; Dizeux A; Baldini C; Le Guillou-Buffello D; Lamuraglia M; Comperat E; Lucidarme O; Bridal SL
Ultrasound Med Biol; 2015 Aug; 41(8):2202-11. PubMed ID: 25980323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
